- Home
- ACRV vs III Comparison
ACRV vs III Comparison
Compare ACRV & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- III
- Stock Information
- Founded
- ACRV 2018
- III 2006
- Country
- ACRV United States
- III United States
- Employees
- ACRV 61
- III N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- III Professional Services
- Sector
- ACRV Health Care
- III Consumer Discretionary
- Exchange
- ACRV Nasdaq
- III Nasdaq
- Market Cap
- ACRV 73.5M
- III 176.6M
- IPO Year
- ACRV 2022
- III 2007
- Fundamental
- Price
- ACRV $2.24
- III $4.00
- Analyst Decision
- ACRV Strong Buy
- III Buy
- Analyst Count
- ACRV 6
- III 1
- Target Price
- ACRV $21.80
- III $3.75
- AVG Volume (30 Days)
- ACRV 162.1K
- III 135.1K
- Earning Date
- ACRV 05-13-2025
- III 03-06-2025
- Dividend Yield
- ACRV N/A
- III 4.50%
- EPS Growth
- ACRV N/A
- III N/A
- EPS
- ACRV N/A
- III 0.06
- Revenue
- ACRV N/A
- III $247,585,000.00
- Revenue This Year
- ACRV N/A
- III N/A
- Revenue Next Year
- ACRV N/A
- III $6.05
- P/E Ratio
- ACRV N/A
- III $68.74
- Revenue Growth
- ACRV N/A
- III N/A
- 52 Week Low
- ACRV $2.14
- III $2.92
- 52 Week High
- ACRV $11.90
- III $4.18
- Technical
- Relative Strength Index (RSI)
- ACRV 22.41
- III 77.65
- Support Level
- ACRV $5.00
- III $3.59
- Resistance Level
- ACRV $5.65
- III $3.79
- Average True Range (ATR)
- ACRV 0.44
- III 0.14
- MACD
- ACRV -0.33
- III 0.05
- Stochastic Oscillator
- ACRV 2.85
- III 100.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.